BusinessInternational Stem Cell Corporation Treated Real Estate Icon Kevin WeeksBy Nasdaq OMXJan 11, 2018, 1:45 PM UTC
BusinessNetworkNewsWire Announces Publication on Alternatives to Nicotine DeliveryBy Nasdaq OMXJan 10, 2018, 1:31 PM UTC
BusinessCrown Bioscience Launches CrownSyn™, an Innovative Bioinformatics Solution that Simplifies the Characterization of Two-Drug Combination StudiesBy Nasdaq OMXJan 9, 2018, 1:00 PM UTC
BusinessAxsome Therapeutics Announces AXS-02 Independent Data Monitoring Committee Recommends Continuation of COAST-1 Trial and Discontinuation of CREATE-1 TrialBy Nasdaq OMXJan 9, 2018, 12:02 PM UTC
BusinessCyclacel Reviews 2017 Achievements and Announces Key Business Objectives for 2018By Nasdaq OMXJan 9, 2018, 12:02 PM UTC
BusinessSV Health Investors Promotes Michael Balmuth to Managing Partner and Houman Ashrafian to PartnerBy Nasdaq OMXJan 8, 2018, 3:25 PM UTC
BusinessStreetwise Reports Publishes Portfolio Manager’s Biotech Watchlist Picks for 2018By Nasdaq OMXJan 8, 2018, 1:45 PM UTC
BusinessNewLink Genetics Outlines 2018 Business Priorities to Support Phase 3 Pivotal Trial of Indoximod Plus PD-1 InhibitorsBy Nasdaq OMXJan 8, 2018, 1:03 PM UTC
